Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Two Ebola Drugs Get Tested On Patients

by Jean-François Tremblay
October 13, 2014 | A version of this story appeared in Volume 92, Issue 41

Patients afflicted with the Ebola virus have received drugs from Chimerix and Fujifilm. Chimerix’s experimental drug brincidofovir was administered last week to Thomas Eric Duncan, a patient at a Dallas hospital who later died. An oral nucleotide analog, the compound may be effective against all five families of double-stranded-DNA-containing viruses that affect humans, the company says. Meanwhile, Fujifilm’s Avigan, approved in Japan as a flu treatment, may have helped cure a nurse who was being treated for ­Ebola and later was released from a French hospital. Fujifilm notes that a German hospital also requested the drug to treat an Ebola patient.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.